Literature DB >> 18771007

In vitro release of curcumin from vehicles containing alginate and cyclodextrin. Studies of curcumin and curcuminoides. XXXIII.

A B Hegge1, R B Schüller, S Kristensen, H H Tønnesen.   

Abstract

Combinations of cyclodextrins and alginates were used to solubilize the hydrophobic compound curcumin in aqueous vehicles intended for topical delivery. A careful selection of the excipients is necessary to achieve a sufficient release of curcumin towards a membrane of hydrophilic character, e.g. mucosa. The aim of the study was to investigate the effect of different combinations of cyclodextrins and alginates on curcumin release towards hydrophilic membranes in vitro. The curcumin flux through semi-permeable membranes of different molecular weight cut-off was measured to differentiate between the flux of curcumin in its uncomplexed form (restricted flux), its uncomplexed form together with its inclusion complexes (partly restricted flux) and the overall flux of curcumin-cyclodextrin complexes and uncomplexed curcumin (unrestricted flux). A high viscosity of the vehicle was expected to inhibit curcumin flux. Vehicles containing 3% alginate were found to have lower unrestricted flux than the vehicles containing 0.5% alginate independent of the type of cyclodextrin used. The results indicate that the unrestricted curcumin flux (e.g. in the case of wounded skin) is rather independent of the composition of the hydrophilic vehicle and mostly limited by the viscosity. However, partly restricted and restricted curcumin flux were found to depend on both the viscosity and the composition of the vehicles. The cyclodextrin with the demonstrated lowest solubilisation capacity (i.e. hydroxypropyl-beta-cyclodextrin) resulted in the highest values of both the restricted and unrestricted curcumin flux. In conclusion, a combination of hydroxypropyl-beta-cyclodextrin and propylene glycol alginate seemed to be the best choice with respect to curcumin solubility and release from the vehicle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18771007

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  6 in total

1.  Complications of Hot Turmeric Use in Acute Trauma.

Authors:  Ammar Al Kashmiri; Mohammed Al Mutani; Anwar Al Zadjali
Journal:  Oman Med J       Date:  2010-07

2.  Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.

Authors:  Prasad R Dandawate; Alok Vyas; Aamir Ahmad; Sanjeev Banerjee; Jyoti Deshpande; K Venkateswara Swamy; Abeda Jamadar; Anne Catherine Dumhe-Klaire; Subhash Padhye; Fazlul H Sarkar
Journal:  Pharm Res       Date:  2012-02-10       Impact factor: 4.200

3.  Oral administration of heat-solubilized curcumin for potentially increasing curcumin bioavailability in experimental animals.

Authors:  Biji T Kurien; R Hal Scofield
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

4.  Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma.

Authors:  Santosh S Dhule; Patrice Penfornis; Trivia Frazier; Ryan Walker; Joshua Feldman; Grace Tan; Jibao He; Alina Alb; Vijay John; Radhika Pochampally
Journal:  Nanomedicine       Date:  2011-08-10       Impact factor: 5.307

Review 5.  Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health.

Authors:  Ali Mobasheri; Yves Henrotin; Hans-Konrad Biesalski; Mehdi Shakibaei
Journal:  Int J Mol Sci       Date:  2012-03-30       Impact factor: 6.208

6.  Curcumin-loaded magnetic nanoparticles for breast cancer therapeutics and imaging applications.

Authors:  Murali M Yallapu; Shadi F Othman; Evan T Curtis; Nichole A Bauer; Neeraj Chauhan; Deepak Kumar; Meena Jaggi; Subhash C Chauhan
Journal:  Int J Nanomedicine       Date:  2012-04-17
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.